Lixte Biotechnology Holdings (LIXT) Enterprise Value (2016)
Lixte Biotechnology Holdings' Enterprise Value history spans 6 years, with the latest figure at -$669771.0 for Q3 2016.
- For Q3 2016, Enterprise Value fell 207.86% year-over-year to -$669771.0; the TTM value through Sep 2016 reached -$669771.0, down 207.86%, while the annual FY2015 figure was -$25281.0, N/A changed from the prior year.
- Enterprise Value reached -$669771.0 in Q3 2016 per LIXT's latest filing, down from -$95776.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$8864.0 in Q3 2014 to a low of -$1.7 million in Q4 2012.
- Average Enterprise Value over 5 years is -$461101.1, with a median of -$140101.0 recorded in 2015.
- Peak YoY movement for Enterprise Value: skyrocketed 98.88% in 2014, then crashed 2354.39% in 2015.
- A 5-year view of Enterprise Value shows it stood at -$1.7 million in 2012, then surged by 71.3% to -$475019.0 in 2013, then soared by 98.13% to -$8864.0 in 2014, then plummeted by 185.21% to -$25281.0 in 2015, then plummeted by 2549.31% to -$669771.0 in 2016.
- Per Business Quant, the three most recent readings for LIXT's Enterprise Value are -$669771.0 (Q3 2016), -$95776.0 (Q2 2016), and -$99386.0 (Q1 2016).